CSPC Pharmaceutical Group Ltd. (1093) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Dec 24

INTEREST(HY) At HKD 23.54 MM has Grown at 43.59%
OPERATING CASH FLOW(Y) Lowest at HKD 10,013.01 MM
ROCE(HY) Lowest at 13.24%

With ROE of 6.15%, it has a Very Expensive valuation with a 3.39 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

HKD 85,193 Million ()

P/E

55.00

Industry P/E

Dividend Yield

0.03%

Debt Equity

-0.28

Return on Equity

5.80%

Price to Book

2.34

Revenue and Profits:

Net Sales:

3,119 Million

(Quarterly Results - Dec 2016)

Net Profit:

536 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

59.92%

6 Months

51.38%

1 Year

9.12%

2 Years

13.65%

3 Years

3.37%

4 Years

-37.42%

5 Years

-8.19%

CSPC Pharmaceutical Group Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.96%

EBIT Growth (5y)

19.40%

EBIT to Interest (avg)

29.07

Debt to EBITDA (avg)

2.63

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.37

Tax Ratio

19.81%

Dividend Payout Ratio

65.03%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

18.91%

ROE (avg)

14.36%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.39

EV to EBIT

39.55

EV to EBITDA

32.74

EV to Capital Employed

4.15

EV to Sales

8.73

PEG Ratio

2.40

Dividend Yield

0.02%

ROCE (Latest)

10.48%

ROE (Latest)

6.15%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2016 is 7.88% vs 2.64% in Dec 2015",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2016 is 26.14% vs 20.79% in Dec 2015",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'16",
        "Dec'15",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,118.70",
          "val2": "2,890.80",
          "chgp": "7.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "764.70",
          "val2": "704.30",
          "chgp": "8.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.60",
          "val2": "13.60",
          "chgp": "-36.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "535.70",
          "val2": "424.70",
          "chgp": "26.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "199.70%",
          "val2": "189.70%",
          "chgp": "1.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -9.50% vs -3.40% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -29.89% vs -7.41% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31,452.50",
          "val2": "34,752.30",
          "chgp": "-9.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,252.70",
          "val2": "8,967.20",
          "chgp": "-19.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "47.40",
          "val2": "28.60",
          "chgp": "65.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-113.30",
          "val2": "-183.20",
          "chgp": "38.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,704.30",
          "val2": "6,710.30",
          "chgp": "-29.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "184.50%",
          "val2": "222.60%",
          "chgp": "-3.81%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY

Dec'16

Dec'15

Change(%)

Net Sales

3,118.70

2,890.80

7.88%

Operating Profit (PBDIT) excl Other Income

764.70

704.30

8.58%

Interest

8.60

13.60

-36.76%

Exceptional Items

0.00

Consolidate Net Profit

535.70

424.70

26.14%

Operating Profit Margin (Excl OI)

199.70%

189.70%

1.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2016 is 7.88% vs 2.64% in Dec 2015

Consolidated Net Profit

YoY Growth in quarter ended Dec 2016 is 26.14% vs 20.79% in Dec 2015

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

31,452.50

34,752.30

-9.50%

Operating Profit (PBDIT) excl Other Income

7,252.70

8,967.20

-19.12%

Interest

47.40

28.60

65.73%

Exceptional Items

-113.30

-183.20

38.16%

Consolidate Net Profit

4,704.30

6,710.30

-29.89%

Operating Profit Margin (Excl OI)

184.50%

222.60%

-3.81%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -9.50% vs -3.40% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -29.89% vs -7.41% in Dec 2023

All Annual Results

Company CV

About CSPC Pharmaceutical Group Ltd.

CSPC Pharmaceutical Group Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available